2m 2m 2m 2m 2m 2m 2m
Cytosorbents (CTSO)
NASDAQ
$0.36-$0.01 (-3.78%)
Price as of Aug 21, 2026 7:26 PM EDT- $23.3MMarket Cap
- -59.48%1-Year Change
- Medical DevicesIndustry
Cytosorbents (CTSO)
$0.36-$0.01 (-3.78%)
CTSO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.37 | ||
Change | +$0.06 (+18.93%) | ||
Open | $0.32 | ||
High | $0.38 | ||
Low | $0.31 | ||
Previous Close | $0.31 | ||
Volume | 326,639 | ||
30-Day Average Volume | 83,164 | ||
1-Week Change | -7.48% | ||
1-Month Change | -6.00% | ||
1-Year Change | -59.48% | ||
3-Year Change | -86.25% | ||
5-Year Change | -95.35% | ||
Fundamentals | |||
Shares Outstanding | 62.8M | ||
Total Assets | $38.0M | ||
Market Cap | $23.3M | ||
Enterprise Value | $36.1M | ||
Period: QTR TTM FY | |||
Revenue | $9.6M | ||
Net Income | -$4.4M | ||
Free Cash Flow | -$597,000.00 | ||
EBIT | -$3.5M | ||
EBITDA | -$3.0M | ||
Net Working Capital | -$8.3M | ||
EPS | -$0.07 | ||
Enterprise Value/EBITDA | -12 | ||
Enterprise Value/Revenue | 4 | ||
P/B | -31 | ||
P/E | -5 | ||
PEG | -0 | ||
Price/Free Cash Flow | -39 | ||
Price/Operating Cash Flow | -40 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 12/05/2014 | ||
Earnings & Revenue